McDermott Will & Schulte‘s competition group is particularly impressive in merger control, FSR and abuse of dominance matters, and is regularly turned to by clients from the energy, pharmaceuticals and transportation sectors. Axel Schulz is particularly focused on the pharmaceuticals sector, demonstrating both contentious and transactional experience. Stéphane Dionnet is a further key contact. Hendrik Viaene left the firm in January 2026.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Axel Schulz brings exceptional strategic insight and leadership.'
- 'I’ve particularly valued their responsiveness, clarity of advice, and ability to remain solution-focused under pressure.'
- ‘The individuals I work with stand out for their sharp intellect, strategic mindset, and consistent professionalism. What sets them apart is their ability to combine legal expertise with a deep understanding of the broader commercial and regulatory landscape.'
- 'The team’s collaborative approach and responsiveness set them apart from other firms. Their professionalism and strategic thinking make them a trusted advisor in high-stakes matters.’
- 'They are highly proactive, with a sharp awareness of public affairs and regulatory dynamics, enabling strategic and well-informed advice. Clients benefit from their ability to anticipate challenges and navigate complex legal and political environments.'
- ‘The team stands out for its strong engagement and unwavering commitment to each case, consistently demonstrating deep analytical skills and exceptional attention to detail.'
Key clients
- Asahi Group
- Swedish Orphan BioVitrum
- Lunate Capital Limited
- Alpha Trains
- Autobrains
- Novo Nordisk A/S
- Nautic Partners
- Alpha Trains
- Pfeifer & Langen-IHKG Group
- Lunate
- Invest-NL
- Phibro Animal Health Corporation
Work highlights
Assisting Soudal in a State aid in-depth investigation launched by the European Commission in September 2019, as well as in an appeal before the European Court of Justice’s Grand Chamber in relation to a state aid and taxation decision rendered by the European Commission in 2016.
Assisting Esko Graphics in a State aid in-depth investigation launched by the European Commission in September 2019, as well as in an appeal before the European Court of Justice’s Grand Chamber in relation to a state aid and taxation decision rendered by the European Commission in 2016.
Advised Phibro on the acquisition of Zoetis’s medicated feed additive and water-soluble product portfolio.
Practice head
Axel Schulz
Other key lawyers
Stéphane Dionnet